Manhattan Pharmaceuticals

Manhattan Pharmaceuticals, Inc. is a specialty healthcare product company focused on developing and commercializing innovative treatments for underserved patient populations. The current portfolio of product candidates includes:* AST-726 – a nasally delivered form of hydroxocobalamin for the treatment of vitamin B 12 deficiency * Hedrin® – a novel, non-pesticide treatment for pediculosis (head lice)* AST-915 – an oral treatment for essential tremor * GEL – a topical gel for the treatment of mild psoriasis Manhattan Pharmaceuticals is located in New York City and is traded on the OTC Bulletin Board® under the ticker symbol “MHAN”.